SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
RPID reported Third quarter ended September 30, 2026 results. The price and volatility reaction is pending.
RPIDearnings

Earnings reactions, page 2

Rapid Micro Biosystems, Inc. (RPID) Q3 FY2026 earnings

November 16, 2026 · SharpeIQ Research Desk

Reported results

  • Total revenue for the third quarter of 2026 was $9.5 million, compared to $7.8 million in the third quarter of 2025.
  • The Company placed 7 Growth Direct systems and completed 12 validations in the third quarter of 2026.
  • Total gross margin was 25.2% for the third quarter of 2026, compared to 8.9% in the third quarter of 2025.
  • Net loss for the third quarter of 2026 was $11.3 million, compared to a net loss of $11.5 million in the third quarter of 2025.
  • Non-GAAP adjusted EBITDA loss for the third quarter of 2026 was $7.9 million, compared to a loss of $9.4 million in the third quarter of 2025.

Notes

The Company is withdrawing its full year 2026 guidance and will delay the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, due to the acquisition announcement.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-16 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →